Gf Fund Management Co. Ltd. Iovance Biotherapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 6,400 shares of IOVA stock, worth $36,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,400Holding current value
$36,992% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IOVA
# of Institutions
340Shares Held
247MCall Options Held
2.51MPut Options Held
3.5M-
Vanguard Group Inc Valley Forge, PA27.5MShares$159 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$141 Million24.02% of portfolio
-
Perceptive Advisors LLC New York, NY22.1MShares$128 Million5.46% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$123 Million0.0% of portfolio
-
State Street Corp Boston, MA12.2MShares$70.8 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $912M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...